Eson Pac are packaging specialists providing solutions for the pharma packaging supply chain. Mayr-Melnhof Group (“MM”) has acquired 100% of the shares in Eson Pac from the majority shareholder Nalka Invest AB as well as the founding family and management minority shareholders. MM is Europe’s leading producer of cartonboard and folding cartons as well as kraft papers and uncoated fine papers.

Vinge’s team consisted of Matthias Pannier, Ulrich Ziche, Måns Håkanson and Elias Bohlin (M&A), Felix Möller and Ellen Flygt (Banking and Finance), Elin Broman and Emil Lindwall (Employment), Michael Montner (IP), Mario Saad (Commercial Agreements), Mika Jordan (IT), Tove Tullberg (Compliance), Frida Ställborn (Real Property), Johan Cederblad and Lina Österberg (Environmental law).

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024